Identification of a Pharmacophore for Thrombopoietic Activity of Small, Non-Peptidyl Molecules. 1. Discovery and Optimization of Salicylaldehyde Thiosemicarbazone Thrombopoietin Mimics
作者:Kevin J. Duffy、Anthony N. Shaw、Evelyne Delorme、Susan B. Dillon、Connie Erickson-Miller、Leslie Giampa、Yifang Huang、Richard M. Keenan、Peter Lamb、Nannan Liu、Stephen G. Miller、Alan T. Price、Jon Rosen、Heather Smith、Kenneth J. Wiggall、Lihua Zhang、Juan I. Luengo
DOI:10.1021/jm025535c
日期:2002.8.1
High-throughputscreening has resulted in the discovery of thiosemicarbazone thrombopoietin mimics. A shared pharmacophore hypothesis between this series and a previously identified class, the pyrazol-4-ylidenehydrazines, led to the rapid optimization of both potency and efficacy of the thiosemicarbazones. The application of high-throughput chemistry and purification techniques allowed for the rapid
Organosulfur modulators of tyrosine phosphatases and their use in the treatment of disease are disclosed.
本发明揭示了酚磷酸酶的有机硫调节剂及其在治疗疾病中的应用。
Thrombopoietin mimetics
申请人:——
公开号:US20040058990A1
公开(公告)日:2004-03-25
Invented are non-peptide TPO mimetics. also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected substituted thiosemicarbazone derivative.